blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3860592

EP3860592 - OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.02.2024
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  09.07.2021
FormerThe international publication has been made
Status updated on  06.06.2020
Most recent event   Tooltip16.02.2024Application deemed to be withdrawnpublished on 20.03.2024  [2024/12]
Applicant(s)For all designated states
CELLIX BIO PRIVATE LIMITED
Plot No. 1177B
Road No. 56, Jubilee Hills
Hyderabad 500033 / IN
[2021/32]
Inventor(s)01 / KANDULA, Mahesh
11-61, East Godavari District G.
Medapadu 533434 / IN
 [2021/32]
Representative(s)Isarpatent
Patent- und Rechtsanwälte Barth
Charles Hassa Peckmann & Partner mbB
Friedrichstrasse 31
80801 München / DE
[2021/32]
Application number, filing date19889347.123.11.2019
[2021/32]
WO2019IB60094
Priority number, dateIN20184104454026.11.2018         Original published format: IN201841044540
IN20194100149112.01.2019         Original published format: IN201941001491
[2021/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020109957
Date:04.06.2020
Language:EN
[2020/23]
Type: A1 Application with search report 
No.:EP3860592
Date:11.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.2020 takes the place of the publication of the European patent application.
[2021/32]
Search report(s)International search report - published on:IN04.06.2020
(Supplementary) European search report - dispatched on:EP22.03.2023
ClassificationIPC:A61K9/00, A61K9/10, A61K31/498, A61K31/4178, A61K31/385, A61K31/4174, A61P17/00, A61P27/00, A61P27/04, C07D233/22
[2023/03]
CPC:
C07D233/22 (EP,IL,KR,US); A61K31/4174 (KR); A61P11/00 (KR);
A61P27/02 (KR); C07C53/126 (US); C07C65/10 (KR);
C07D213/55 (US); C07D213/56 (US); C07D339/04 (US);
C07D401/02 (KR); C07D403/12 (KR); C07D409/02 (KR);
C07D493/22 (KR) (-)
Former IPC [2021/32]A61K31/4174, A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/32]
TitleGerman:OPHTHALMISCHE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON HAUT- UND AUGENKRANKHEITEN[2021/32]
English:OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES[2021/32]
French:COMPOSITIONS OPHTALMIQUES ET MÉTHODES DE TRAITEMENT DE MALADIES OCULAIRES ET DE MALADIES CUTANÉES[2021/32]
Entry into regional phase07.05.2021National basic fee paid 
07.05.2021Search fee paid 
07.05.2021Designation fee(s) paid 
07.05.2021Examination fee paid 
Examination procedure07.05.2021Examination requested  [2021/32]
17.11.2021Amendment by applicant (claims and/or description)
24.10.2023Application deemed to be withdrawn, date of legal effect  [2024/12]
14.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/12]
Fees paidRenewal fee
30.11.2021Renewal fee patent year 03
30.11.2022Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.11.202305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2006084174  (YU RUEY J [US], et al) [I] 1,5-8 * examples 9-11; claims 1-34,44 *;
 [A]US2009124683  (GARNER WILLIAM [US], et al) [A] 1,5-8 * paragraphs [0033] , [0051]; claims 18,19 *;
 [XY]US2013079379  (SHANLER STUART D [US], et al) [X] 1,5-7 * paragraphs [0101] , [0139] , [0146]; claim 17 * [Y] 1,5-8;
 [XY]US2014113947  (SHANLER STUART D [US], et al) [X] 1,5-7 * paragraphs [0058] , [0079]; claim 1 * [Y] 1,5-8;
 [I]WO2014104784  (CHONG KUN DANG PHARM CORP [KR]) [I] 1,5-8 * page 10, line 10; figure 1; claims 8,17,24-30; table 2 *;
 [XI]WO2014158119  (SANTA FARMA İLAÇ SANAYİ A Ş [TR]) [X] 1,5-7 * example -; claim 4 *[I] 1,5-8
International search[X]WO2012118704  (VOOM LLC [US], et al) [X] 1, 5-7 and 17 * pages 11-16, claims 1-10 *;
 [X]US2013079379  (SHANLER STUART D [US], et al) [X] 1, 5-7 and 17* abstract, paragraphs- [0101], [0122]-[0124], [0130], [0133], [0138]-[0140], [0146], [0156] *;
 [X]US2014113947  (SHANLER STUART D [US], et al) [X] 1, 5-7 and 17 * paragraphs- [0078]-[0090], calims 1-2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.